https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-08644-8
Introduction The urgent need for new treatments for multidrug-resistant tuberculosis (MDR-TB) and pre-extensively drug-resistant tuberculosis (pre-XDR-TB) is evident. However, the classic randomized controlled trial (RCT) approach faces ethical and practical …
Create an account or login to join the discussion